| Authors: |
Lee R; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Arnold DE; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Parta M; Clinical Research Directorate/Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Bethesda, MD, United States of America., Pai SY; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Dekker JP; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Das S; Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, USA., Lee R; Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, USA., Cuellar-Rodriguez J; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Bergerson J; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America. Electronic address: jenna.bergerson@nih.gov., Czech MM; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America. Electronic address: mary.czech@nih.gov. |
